The Critical Path Initiative: Leveraging Collaborations to Enhance Regulatory Science

The Critical Path Institute’s Approach to Precompetitive Sharing and Advancing Regulatory Science

(2010) R L Woosley et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

(2010) Frank Dieterle et al.   NATURE BIOTECHNOLOGY

Transporters in drug development: advancing on the Critical Path

(2010) Shiew-Mei Huang et al.   NATURE REVIEWS DRUG DISCOVERY

Membrane transporters in drug development

(2010)   NATURE REVIEWS DRUG DISCOVERY

How a US Regulator Can Encourage New Science

(2009) D C Throckmorton   CLINICAL PHARMACOLOGY & THERAPEUTICS

Novel Biomarkers of Acute Kidney Toxicity

(2009) F M Goodsaid et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The International Transporter Consortium: A Collaborative Group of Scientists From Academia, Industry, and the FDA

(2009) S-M Huang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS